Silver Book Fact

Compared to standard coverage, 3 years of full coverage for prevention medications will reduce mortality and reinfarction rates and will save $5,974 per patient.

Choudhry, Niteesh, Jerry Avorn, Elliot M. Antman, Sebastian Schneeweiss, and William H. Shrank. Should Patients Receive Secondary Prevention Medications For Free After A Myocardial Infarction? An economic analysis. Health Affairs. 2007; 26(1): 186-194. https://www.healthaffairs.org/doi/abs/10.1377/hlthaff.26.1.186?url_ver=Z39.88-2003&rfr_id=ori%3Arid%3Acrossref.org&rfr_dat=cr_pub%3Dpubmed

Reference

Title
Should Patients Receive Secondary Prevention Medications For Free After A Myocardial Infarction? An economic analysis
Publication
Health Affairs
Publisher
Project HOPE
Publication Date
2007
Authors
Choudhry, Niteesh, Jerry Avorn, Elliot M. Antman, Sebastian Schneeweiss, and William H. Shrank
Volume & Issue
Volume 26, Issue 1
Pages
186-194
URL
Read Full Resource

Categories

  • Innovative Medical Research
  • Economic Value

Related Facts

  • Every additional dollar spent on antiplatelet therapy versus aspirin for the prevention of stroke in high-risk patients, has produced health gains valued between $2 and $6.  
  • The projected economic value of eliminating deaths from heart disease is approximately $48 trillion.  
  • Primary angioplasty reduces 30-day mortality risk by 34% to 50%.  
  • Using medical imaging to diagnose and treat stroke leads to better outcomes and shorter hospital stays, which yields a net economic benefit of about $8 billion over 10 years.  
  • From 1999-2000, average blood pressures for Americans age 40 and older would have been 10-13% higher without antihypertensive drug therapy.